These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28392113)

  • 1. The Transcription Terminator Rho: A First Bacterial Prion.
    Pallarès I; Ventura S
    Trends Microbiol; 2017 Jun; 25(6):434-437. PubMed ID: 28392113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bacterial global regulator forms a prion.
    Yuan AH; Hochschild A
    Science; 2017 Jan; 355(6321):198-201. PubMed ID: 28082594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The many shades of prion strain adaptation.
    Baskakov IV
    Prion; 2014; 8(2):169-72. PubMed ID: 24518385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yeast prions: structure, biology, and prion-handling systems.
    Wickner RB; Shewmaker FP; Bateman DA; Edskes HK; Gorkovskiy A; Dayani Y; Bezsonov EE
    Microbiol Mol Biol Rev; 2015 Mar; 79(1):1-17. PubMed ID: 25631286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Rho Termination Factor of Clostridium botulinum Contains a Prion-Like Domain with a Highly Amyloidogenic Core.
    Pallarès I; Iglesias V; Ventura S
    Front Microbiol; 2015; 6():1516. PubMed ID: 26779170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prion-like RNA-processing protein HNRPDL forms inherently toxic amyloid-like inclusion bodies in bacteria.
    Navarro S; Marinelli P; Diaz-Caballero M; Ventura S
    Microb Cell Fact; 2015 Jul; 14():102. PubMed ID: 26160665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of amyloid aggregates using agarose gel electrophoresis.
    Bagriantsev SN; Kushnirov VV; Liebman SW
    Methods Enzymol; 2006; 412():33-48. PubMed ID: 17046650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic prions and other human neurodegenerative proteinopathies.
    Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
    Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tauons and prions: infamous cousins?
    Novak P; Prcina M; Kontsekova E
    J Alzheimers Dis; 2011; 26(3):413-30. PubMed ID: 21694453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prions: protein aggregation and infectious diseases.
    Aguzzi A; Calella AM
    Physiol Rev; 2009 Oct; 89(4):1105-52. PubMed ID: 19789378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the aggregation propensity of prion sequences.
    Espargaró A; Busquets MA; Estelrich J; Sabate R
    Virus Res; 2015 Sep; 207():127-35. PubMed ID: 25747492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fitting yeast and mammalian prion aggregation kinetic data with the Finke-Watzky two-step model of nucleation and autocatalytic growth.
    Watzky MA; Morris AM; Ross ED; Finke RG
    Biochemistry; 2008 Oct; 47(40):10790-800. PubMed ID: 18785757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion-like transmission of pathogenic protein aggregates in genetic models of neurodegenerative disease.
    Pearce MM
    Curr Opin Genet Dev; 2017 Jun; 44():149-155. PubMed ID: 28441621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural and pathogenic protein sequence variation affecting prion-like domains within and across human proteomes.
    Cascarina SM; Ross ED
    BMC Genomics; 2020 Jan; 21(1):23. PubMed ID: 31914925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dictyostelium discoideum has a highly Q/N-rich proteome and shows an unusual resilience to protein aggregation.
    Malinovska L; Palm S; Gibson K; Verbavatz JM; Alberti S
    Proc Natl Acad Sci U S A; 2015 May; 112(20):E2620-9. PubMed ID: 25941378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion-like proteins and their computational identification in proteomes.
    Batlle C; Iglesias V; Navarro S; Ventura S
    Expert Rev Proteomics; 2017 Apr; 14(4):335-350. PubMed ID: 28271922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological functions of amyloids: facts and hypotheses].
    Mironova LN; Goginashvili AI; Ter-Avanesian MD
    Mol Biol (Mosk); 2008; 42(5):798-808. PubMed ID: 18988529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolutionary behaviour of bacterial prion-like proteins.
    Harrison PM
    PLoS One; 2019; 14(3):e0213030. PubMed ID: 30835736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous aggregates promote de novo prion appearance via more than one mechanism.
    Arslan F; Hong JY; Kanneganti V; Park SK; Liebman SW
    PLoS Genet; 2015 Jan; 11(1):e1004814. PubMed ID: 25568955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.